Navigation Links
S*BIO and Tragara Announce an Exclusive Worldwide License Agreement for Novel Multi-kinase Inhibitor SB1317
Date:1/20/2009

euticals, Inc. for its development and commercialization.

In line with its vision to be a leading fully-integrated oncology-focused biotech company in Asia Pacific, S*BIO has established a state-of-the-art R&D infrastructure, complemented by a strong clinical development team. S*BIO has strong links with a network of medical oncologists in Asia Pacific and its investors include Bio*One Capital, Aravis Ventures, Novartis Bioventures and other international funds. More information about S*BIO can be found at www.sbio.com. 

    S*BIO Pte Ltd:                      Russo Partners:
    Stephen Keith Rhind, Ph.D.          Tony Russo +1 212-845-4251
    Senior Vice President,              Tony.Russo@russopartnersllc.com
    Corporate Development               Andreas Marathovouniotis
    Tel: +65 6827 5000 (Singapore)      +1 212-845-4253
    Stephen_rhind@sbio.com              Andreas.Marathis@russopartnersllc.com

    Tragara Pharmaceuticals Inc.:
    Chris LeMasters
    Chief Business Officer
    Tel: +1 858 350 6913
    Clemasters@tragarapharma.com


'/>"/>
SOURCE S*BIO Pte Ltd
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. S*BIO Receives Orphan Drug Designation for JAK2 Inhibitor SB1518 for the Treatment of Myeloproliferative Disorders
2. S*BIO Completes US$26 Million Equity Financing
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
5. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
6. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
7. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
8. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
9. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
10. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
11. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...v. 19 Danish Prince Joachim inaugu...ol plant in Kalundborg, Denmark, on Wednesday, Nov... and largest 2nd generation ethanol demonstration ...used in the plant,s innovative process for convert..., was the first to market with commercial enzymes ...
(Date:11/19/2009)...ETHESDA, Md., Nov. 19 Sp...in biotechnology for diabetes therapy, and a provi...s to food, supplement, biotechnology and pharmaceu...viously reported $6.3 million registered direct pl...ares of its common stock and warrants to purchase ...
(Date:11/19/2009)...Pa. and WALTHAM, Mass., Nov. 19 Ar...rces find that the leading driver of antibiotic se...-spectrum activity against gram-positive and gram-...s that can cause nosocomial pneumonia, surveyed Eu...for agents that provide appropriate coverage again...
(Date:11/19/2009)... Top LASIK surgeons and recognized refractive and...Surgeons made brought their fellow surgeons up-to-...on surgery, cataract surgery, and ophthalmology in...y of Ophthalmology (AAO) annual meeting in San Fra...char Tauber, Dr. David Huang, MD, Dr. Randy Epstei...
Breaking Biology Technology:DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 2Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 3Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 4Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 5Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 6Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 7Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 8Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 9
...e, Wis. - The Wisconsin Department of Agricultur...ded a $50,000 grant to the University of Wisconsi...gradable plastics made from Wisconsin agricultural...headed by Sarah Gong, assistant professor of mecha...n the state,s plastics industry and encourage tech...
... Wis. - Drawing on the immense popularity of the ...m, American Idol , computer software designers ...g to aspiring pop stars. , , Sony Media Software ,...DVD, and audio production, has signed an agreement...lop two software products based on the show, which...
... Wis . - As any gaming guru will tell you, using t...y a new idea. For the medical profession, however,...bably has never been identified as a revolutionary... , ,Kron, a physician with ties to the entertainme...mpany, Medical Cyberworlds, that might have found ...
Other Biology Technology:UWM receives state funding for plastics research 2American Idol spurs music software 2Doctor using new media to break down barriers 2Doctor using new media to break down barriers 3Doctor using new media to break down barriers 4
(Date:11/19/2009)...ring Harbor, NY A four-year, multi-institutional ...ry (CSHL) scientists culminated today in publicati...Science revealing in unprecedented detail the DNA...s it is commonly called by North American consumer... the most valuable agricultural crop grown in the ...
(Date:11/19/2009)..., WALL, N.J., Nov. 19 B...YI), a leader in wireless public safety and finger...ed that the Special Shareholder Meeting held today...use a quorum was not present. ,, (Logo: http:/... ,, While an impressive 99.3% of the 35 million...
(Date:11/19/2009)... Tenn., Nov. 19, 2009 -- Sustainable farming, init...generations, may also play a role in maintaining a...Department of Energy,s Oak Ridge and Los Alamos na...are exploring the large potential of the earth,s s...that new land-use practices could greatly reduce U...
Breaking Biology News(10 mins):Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 2Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 3Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 4BIO-key(R) Provides Update to Special Shareholder Meeting 2BIO-key(R) Provides Update to Special Shareholder Meeting 3ORNL, Los Alamos pioneer new approach to assist scientists, farmers 2ORNL, Los Alamos pioneer new approach to assist scientists, farmers 3Zucker Hillside Researchers to Receive Large Federal Grant to Test for the Early Treatment of Schizophrenia 52341 1Zucker Hillside Researchers to Receive Large Federal Grant to Test for the Early Treatment of Schizophrenia 52341 2Zucker Hillside Researchers to Receive Large Federal Grant to Test for the Early Treatment of Schizophrenia 52341 3Zucker Hillside Researchers to Receive Large Federal Grant to Test for the Early Treatment of Schizophrenia 52341 4Tobira Therapeutics Inc Announces Phase I Data Demonstrating Pharmacokinetic Properties of TAK 652 for the Treatment of HIV 13130 1Tobira Therapeutics Inc Announces Phase I Data Demonstrating Pharmacokinetic Properties of TAK 652 for the Treatment of HIV 13130 2A drug dispensing contact lens 13129 1A drug dispensing contact lens 13129 2
...ectious diseases run in families because one inher...enerally agree that an individual,s genetic makeup...nfectious disease, new findings from researchers i...ror in a single gene is enough to dramatically alt...tions. , Howard Hughes Medical Institute (HHMI)...
...ts do not haphazardly flail about looking for a ho...plants and identify potential hosts by their emiss...cologists. , "We are interested in how plants resp... insect interactions," says Dr. Consuelo M. De Mor...urprising to see how little was available on how a...
...ference between a lifeless sack of chemicals and a...d, according to Stanford biophysical chemist Steve...ty of California-Davis and Lawrence Livermore Nati...ell membranes with unprecedented resolution-on the...vidual molecules but much smaller than entire cell...
Other Biology News:Inheriting a tendency to brain infection 2Inheriting a tendency to brain infection 3Parasitic plants sniff out hosts 2Parasitic plants sniff out hosts 3With record resolution and sensitivity, tool images how life organizes in a cell membrane 2With record resolution and sensitivity, tool images how life organizes in a cell membrane 3With record resolution and sensitivity, tool images how life organizes in a cell membrane 4With record resolution and sensitivity, tool images how life organizes in a cell membrane 5With record resolution and sensitivity, tool images how life organizes in a cell membrane 6
Goat Anti-ORC2L Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-Human WASF2 Polyclonal Antibody, Unconjugated from ABR-Affinity BioReagents
Anti-7H6 Antigen (tight-junction associated protein antigen) Monoclonal Antibody, Unconjugated, Clone 7H6 from Cell Sciences
T7Select Biopanning Kit from Novagen
Biology Products: